Labcorp Enters Partnership With Waters to Expand HPV Testing

09:00 AM EDT, 10/23/2026 (MT Newswires) -- Labcorp (LH) said Friday it has entered into a partnership with Waters (WAT) to expand access to human papillomavirus testing through its nationwide laboratory network starting late this year. Labcorp plans to offer the BD Onclarity HPV test, approved by the US Food and Drug Administration, for clinician-collected and self-collected samples in clinics, patient service centers, and at home, the company said. The test identifies specific HPV strains to help guide patient care based on cervical cancer risk, it added.